Simona Ultimo

Ferrara, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.

Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.

Journal: Oncotarget
Published: January 05, 2018

Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.

Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.

Journal: Oncotarget
Published: December 26, 2017

Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases.

Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases.

Journal: Oncotarget
Published: December 21, 2017

Impact of physical exercise in cancer survivors during and after antineoplastic treatments.

Impact of physical exercise in cancer survivors during and after antineoplastic treatments.

Journal: Oncotarget
Published: December 17, 2017

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model.

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model.

Journal: Molecular therapy. Nucleic acids
Published: December 12, 2017

Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.

Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.

Journal: Journal of cellular physiology
Published: August 10, 2017

PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines.

PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines.

Journal: Oncotarget
Published: December 08, 2016

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.

Journal: Oncotarget
Published: August 04, 2016

Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.

Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.

Journal: Oncotarget
Published: May 05, 2016

The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells.

The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells.

Journal: Oncotarget
Published: February 26, 2015

Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.

Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.

Journal: Oncotarget
Published: December 22, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026